Lung Cancer
Volume 69, Issue 1 , Pages 26-32 , July 2010

Thromboxane receptor α mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells

  • Jingyan Wei

      Affiliations

    • Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, United States
    • College of Pharmacy, Jilin University, Changchun, China
    • Current address: College of Pharmacy, Jilin University, Changchun, China.
    • ,
  • Weili Yan

      Affiliations

    • Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, United States
    • Current address: College of Pharmacy, Auburn University, Auburn, AL 36849, United Sates.
    • ,
  • Xiuling Li

      Affiliations

    • Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, United States
    • ,
  • Yunfei Ding

      Affiliations

    • Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, United States
    • Current address: College of Pharmacy, Auburn University, Auburn, AL 36849, United Sates.
    • ,
  • Hsin-Hsiung Tai

      Affiliations

    • Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 859 257 1837; fax: +1 859 257 7585.

Received 15 June 2009 ,Revised 9 September 2009 ,Accepted 20 September 2009.

References 

  1. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931–10934
  2. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–395
  3. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–676
  4. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela D, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem. 1994;269:6271–6274
  5. Tuder R, Flook B, Voelkel N. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest. 1995;95:1798–1807
  6. Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, et al. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol. 2000;279:L371–L378
  7. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3:401–410
  8. Hoper MM, Voelkel NF, Betes TO, Allard JD, Horan M, Shepherd D, et al. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am J Respir Cell Mol Biol. 1997;17:748–756
  9. Harada S, Najy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, et al. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest. 1994;93:2490–2496
  10. Nie D, Krishnamoorthy S, Jin R, Tang K, Chen Y, Qiao Y, et al. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem. 2006;281:18601–18609
  11. Fujino H, Regan JW. Prostanoid receptors and phosphatidyl inositol 3-kinase: a pathway to cancer?. Trends Pharmacol Sci. 2003;24:335–340
  12. Majima M, Amano H, Hayashi I. Prostanoid receptor signaling relevant to tumor growth and angiogenesis. Trends Pharmacol Sci. 2003;24:524–529
  13. Raychowdhury MK, Yukawa M, Collins LJ, McGray SH, Kent KC, Ware JA. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane receptor. J Biol Chem. 1994;269:19256–19261
  14. Chen GG, Lee TW, Yip JHY, Xu H, Lee IKY, Mok TSK, et al. Increased thromboxane B2 levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma. Cancer Lett. 2006;234:193–198
  15. Watkins G, Douglas-Jones A, Mansel RE, Jiang WG. Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer. Int Semin Surg Oncol. 2005;2:23–30
  16. Moussa O, Yordy JS, Abol-Enein H, Sinha D, Bissada NK, Halushka PV, et al. Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res. 2005;65:11581–11587
  17. Pradono P, Tazawa R, Maemondo M, Tanaka M, Usui K, Saijo Y, et al. Gene transfer of thromboxane A2 synthase and prostaglandin I2 synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res. 2002;62:63–66
  18. Yan W, Tai HH. Glycogen synthase kinase-3 phosphorylation, T-cell factor signaling activation and cell morphology change following stimulation of thromboxane receptor α. J Pharmacol Exp Ther. 2006;317:267–274
  19. Wei J, Yan W, Li X, Chang WC, Tai HH. Activation of thromboxane receptor α induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cell. Biochem Pharmacol. 2007;74:787–800
  20. Zhou HP, Yan FX, Tai HH. PhosphorylatIon and desensitization of the human thromboxane receptor by G protein-coupled receptor kinases. J Pharmacol Exp Ther. 2001;298:1243–1251
  21. Anderson PH, Loughlin PDO, May BK, Morris HA. Quantitation of mRNA for vitamin D metabolic enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real time reverse transcriptase-polymerase chain reaction. J Mol Endocrinol. 2003;31:123–132
  22. Ding Y, Tong M, Liu S, Moscow JA. Tai HH. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. Carcinogenesis. 2005;26:65–72
  23. Morinelli TA, Oatis JE, Okwu AK, Mais DE, Mayeux PR, Masuda A, et al. Characterization of a 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther. 1989;251:557–562
  24. Miggin SM, Kinsella BT. Regulation of extracellular signal-regulated kinase cascades by α- and β-isoforms of the human thromboxane A2 receptor. Mol Pharmacol. 2002;61:817–831
  25. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95–105
  26. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst. 1996;82:4–6
  27. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg. 1997;132:541–546
  28. Tsujii M, Kawano S, Tsujii S, Sawaoka H, Hori H, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705–716
  29. Amano H, Hayashi H, Endo H, Kitasato H, Yamashina S, Maruyama T, et al. Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med. 2003;197:221–231
  30. Fukuda R, Kelly B, Semenza GL. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 2003;63:2330–2334
  31. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 1999;59:4574–4577
  32. Nie D, Lamberti M, Zacharek A, Li L, Szekeres K, Tang K, et al. Thromboxane A2 regulation of endothelial cell migration, angiogenesis and tumor metastasis. Biochem Biophys Res Commun. 2000;267:245–251
  33. Arisato T, Hashiguchi T, Sarker KP, Arimura K, Asano M, Matsuo K, et al. Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region. J Thromb Haemost. 2003;1:2589–2593
  34. Rhee JS, Black M, Achubert U, Fisher S, Morgenstern E, Hamms HP, et al. The functional role of blood platelet components in angiogenesis. Thromb Haemost. 2004;92:394–402
  35. Amano H, Ando K, Minamida S, Hayashi I, Ogino M, Yamashima S, et al. Adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in vivo. Jpn J Pharmacol. 2001;87:181–188
  36. Regan JW. EP2 and EP4 prostanoid receptor signaling. Life Sci. 2003;74:143–153
  37. Nambe T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, et al. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 1993;315:166–170
  38. Hirata T, Ushikubi F, Kakizuka A, Okuma M, Narumiya S. Two thromboxane A2 receptors isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to leu mutation. J Clin Invest. 1996;97:949–956
  39. Ashton AW, Ware JA. Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cells differentiation and migration. Circ Res. 2004;95:372–379
  40. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, et al. Prostaglandin E2 activates mitogen-activated protein kinase/ERK pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res. 2005;65:6275–6281

PII: S0169-5002(09)00493-0

doi: 10.1016/j.lungcan.2009.09.009

Lung Cancer
Volume 69, Issue 1 , Pages 26-32 , July 2010

Article Tools

* Image Usage & Resolution